Findings

What do systematic reviews say?

5 questions · 5 findings · 1 reviews · HIV/AIDS

No studies found 0 · 0%GRADE not reported 0 · 0%Very low 5 · 100%Low 0 · 0%Moderate 0 · 0%High 0 · 0%

Complete response plus partial response Length of · Kaposi sarcoma in children with HIV‐1 infection

It is very uncertain whether chemotherapy + ART changes complete/Partial Response to Tx compared with chemotherapy Alone (very low certainty).

1 finding from 1 review

Treatment of Kaposi sarcoma in children with HIV‐1 infection 2014 · Cochrane Headline outcomes only
RR 1.47 [0.87, 2.49]
36 participants
Very low

Complete/Partial Among Known Outcome · Kaposi sarcoma in children with HIV‐1 infection

It is very uncertain whether chemotherapy + ART changes complete/Partial Among Known Outcome compared with chemotherapy Alone (very low certainty).

1 finding from 1 review

Treatment of Kaposi sarcoma in children with HIV‐1 infection 2014 · Cochrane Headline outcomes only
RR 1.01 [0.81, 1.27]
30 participants
Very low

Complete response · Kaposi sarcoma in children with HIV‐1 infection

It is very uncertain whether chemotherapy + ART changes complete Response to Tx compared with chemotherapy Alone (very low certainty).

1 finding from 1 review

Treatment of Kaposi sarcoma in children with HIV‐1 infection 2014 · Cochrane Headline outcomes only
RR 6.54 [1, 42.86]
36 participants
Very low

Complete Among Known Outcome · Kaposi sarcoma in children with HIV‐1 infection

It is very uncertain whether chemotherapy + ART changes complete Among Known Outcome compared with chemotherapy Alone (very low certainty).

1 finding from 1 review

Treatment of Kaposi sarcoma in children with HIV‐1 infection 2014 · Cochrane Headline outcomes only
RR 4.25 [0.7, 25.91]
30 participants
Very low

All‐cause mortality · Kaposi sarcoma in children with HIV‐1 infection

It is very uncertain whether chemotherapy + ART changes mortality compared with chemotherapy Alone (very low certainty).

1 finding from 1 review

Treatment of Kaposi sarcoma in children with HIV‐1 infection 2014 · Cochrane Headline outcomes only
RR 0.46 [0.29, 0.73]
98 participants
Very low